BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 24548786)

  • 1. Dysregulation of group-I metabotropic glutamate (mGlu) receptor mediated signalling in disorders associated with Intellectual Disability and Autism.
    D'Antoni S; Spatuzza M; Bonaccorso CM; Musumeci SA; Ciranna L; Nicoletti F; Huber KM; Catania MV
    Neurosci Biobehav Rev; 2014 Oct; 46 Pt 2(Pt 2):228-41. PubMed ID: 24548786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective Disruption of Metabotropic Glutamate Receptor 5-Homer Interactions Mimics Phenotypes of Fragile X Syndrome in Mice.
    Guo W; Molinaro G; Collins KA; Hays SA; Paylor R; Worley PF; Szumlinski KK; Huber KM
    J Neurosci; 2016 Feb; 36(7):2131-47. PubMed ID: 26888925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Arrestin2 Couples Metabotropic Glutamate Receptor 5 to Neuronal Protein Synthesis and Is a Potential Target to Treat Fragile X.
    Stoppel LJ; Auerbach BD; Senter RK; Preza AR; Lefkowitz RJ; Bear MF
    Cell Rep; 2017 Mar; 18(12):2807-2814. PubMed ID: 28329674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A reduced number of metabotropic glutamate subtype 5 receptors are associated with constitutive homer proteins in a mouse model of fragile X syndrome.
    Giuffrida R; Musumeci S; D'Antoni S; Bonaccorso CM; Giuffrida-Stella AM; Oostra BA; Catania MV
    J Neurosci; 2005 Sep; 25(39):8908-16. PubMed ID: 16192381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Group I metabotropic glutamate receptors: a role in neurodevelopmental disorders?
    Catania MV; D'Antoni S; Bonaccorso CM; Aronica E; Bear MF; Nicoletti F
    Mol Neurobiol; 2007 Jun; 35(3):298-307. PubMed ID: 17917118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The state of synapses in fragile X syndrome.
    Pfeiffer BE; Huber KM
    Neuroscientist; 2009 Oct; 15(5):549-67. PubMed ID: 19325170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blunted type-5 metabotropic glutamate receptor-mediated polyphosphoinositide hydrolysis in two mouse models of monogenic autism.
    Di Menna L; Orlando R; D'Errico G; Ginerete RP; Machaczka A; Bonaccorso CM; Arena A; Spatuzza M; Celli R; Alborghetti M; Ciocca E; Zuena AR; Scioli M; Bruno V; Battaglia G; Nicoletti F; Catania MV
    Neuropharmacology; 2023 Nov; 238():109642. PubMed ID: 37392820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragile X mental retardation protein (FMRP) and metabotropic glutamate receptor subtype 5 (mGlu5) control stress granule formation in astrocytes.
    Di Marco B; Dell'Albani P; D'Antoni S; Spatuzza M; Bonaccorso CM; Musumeci SA; Drago F; Bardoni B; Catania MV
    Neurobiol Dis; 2021 Jul; 154():105338. PubMed ID: 33775821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential therapeutic interventions for fragile X syndrome.
    Levenga J; de Vrij FM; Oostra BA; Willemsen R
    Trends Mol Med; 2010 Nov; 16(11):516-27. PubMed ID: 20864408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autism, Alzheimer disease, and fragile X: APP, FMRP, and mGluR5 are molecular links.
    Sokol DK; Maloney B; Long JM; Ray B; Lahiri DK
    Neurology; 2011 Apr; 76(15):1344-52. PubMed ID: 21482951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of the PI3K enhancer PIKE mediates deficits in synaptic plasticity and behavior in fragile X syndrome.
    Gross C; Chang CW; Kelly SM; Bhattacharya A; McBride SM; Danielson SW; Jiang MQ; Chan CB; Ye K; Gibson JR; Klann E; Jongens TA; Moberg KH; Huber KM; Bassell GJ
    Cell Rep; 2015 May; 11(5):727-36. PubMed ID: 25921541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disrupted Homer scaffolds mediate abnormal mGluR5 function in a mouse model of fragile X syndrome.
    Ronesi JA; Collins KA; Hays SA; Tsai NP; Guo W; Birnbaum SG; Hu JH; Worley PF; Gibson JR; Huber KM
    Nat Neurosci; 2012 Jan; 15(3):431-40, S1. PubMed ID: 22267161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Adulthood Onset mGlu5 Signaling Saves Prefrontal Function in the Fragile X Mouse.
    Martin HGS; Lassalle O; Manzoni OJ
    Cereb Cortex; 2017 Dec; 27(12):5592-5602. PubMed ID: 27797833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamate Delta-1 Receptor Regulates Metabotropic Glutamate Receptor 5 Signaling in the Hippocampus.
    Suryavanshi PS; Gupta SC; Yadav R; Kesherwani V; Liu J; Dravid SM
    Mol Pharmacol; 2016 Aug; 90(2):96-105. PubMed ID: 27231330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in mGlu5 receptor-dependent synaptic plasticity and coupling to homer proteins in the hippocampus of Ube3A hemizygous mice modeling angelman syndrome.
    Pignatelli M; Piccinin S; Molinaro G; Di Menna L; Riozzi B; Cannella M; Motolese M; Vetere G; Catania MV; Battaglia G; Nicoletti F; Nisticò R; Bruno V
    J Neurosci; 2014 Mar; 34(13):4558-66. PubMed ID: 24672001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role for metabotropic glutamate receptor 5 (mGluR5) in the pathogenesis of fragile X syndrome.
    Dölen G; Bear MF
    J Physiol; 2008 Mar; 586(6):1503-8. PubMed ID: 18202092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striatal mGlu
    Jong YI; Izumi Y; Harmon SK; Zorumski CF; ÓMalley KL
    J Biol Chem; 2023 Aug; 299(8):104949. PubMed ID: 37354970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reciprocal regulation of spontaneous synaptic vesicle fusion by Fragile X mental retardation protein and group I metabotropic glutamate receptors.
    Subrahmanyam R; Dwivedi D; Rashid Z; Bonnycastle K; Cousin MA; Chattarji S
    J Neurochem; 2021 Sep; 158(5):1094-1109. PubMed ID: 34327719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms underlying prelimbic prefrontal cortex mGlu
    Joffe ME; Santiago CI; Stansley BJ; Maksymetz J; Gogliotti RG; Engers JL; Nicoletti F; Lindsley CW; Conn PJ
    Neuropharmacology; 2019 Jan; 144():19-28. PubMed ID: 30326237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional partnership between mGlu3 and mGlu5 metabotropic glutamate receptors in the central nervous system.
    Di Menna L; Joffe ME; Iacovelli L; Orlando R; Lindsley CW; Mairesse J; Gressèns P; Cannella M; Caraci F; Copani A; Bruno V; Battaglia G; Conn PJ; Nicoletti F
    Neuropharmacology; 2018 Jan; 128():301-313. PubMed ID: 29079293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.